TLSI
Ticker
TriSalus Life Sciences, Inc.
TLSI · Healthcare · TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-on…TriSalus Life Sciences, Inc. (TLSI), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 6 purchases and 0 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed May 15 and filed May 18. The most active filer was Michael P Stansky with 2 filings.
Add to watchlistFilings, ttm
6
6 buys · 0 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$3.5M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
May 15
Filed May 18
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$5.35 (+9.6%)
Adjusted for splits and dividends.
Volume by month
Buys $3.9M
Sells $111K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
MSRecent filings
Mats WahlstromPURCHASE
Director
$152K60,000 sh × $2.53
Exec May 15
Filed May 18 · 4:42 PM ET Michael P StanskyPURCHASE Director $1.5M
610,000 sh across 2 lots
Exec May 15
Filed May 18 · 4:42 PM ET Mary T SzelaPURCHASE CEO and President $103K
39,682 sh × $2.59
Exec May 15
Filed May 18 · 4:42 PM ET William VallePURCHASE Director $125K
30,487 sh × $4.10
Exec Feb 23
Filed Feb 23 · 4:08 PM ET Mary T SzelaPURCHASE CEO and President $125K
30,487 sh × $4.10
Exec Feb 23
Filed Feb 23 · 4:08 PM ET Michael P StanskyPURCHASE Director $1.5M
361,098 sh across 2 lots
Exec Feb 23
Filed Feb 23 · 4:08 PM ET James Emmett YoungPURCHASE Chief Financial Officer $130K
24,000 sh × $5.40
Exec Jan 27 2025
Filed Jan 29 2025 · 5:30 PM ET Equity AB FrankeniusPURCHASE 10% owner $250K
62,972 sh × $3.97
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET Arjun JJ DesaiSALE Director $111K
30,000 sh × $3.69
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET